Most Parikweneh participants named insulin as a biomedical remedy for diabetes (62.5%; 30/48), whereas only some named at least one antidiabetic pill, i.e. metformin, stagid, amaryl, velmetia or glibenclamide (8.33%; 4/48). Here, INS is linked to diabetes mellitus.